Investments
15Portfolio Exits
3
Want to inform investors similar to Origin Capital Group about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Origin Capital Group News
May 3, 2016
Fintech challenges Veda, Dun & Bradstreet Fintech challenges Veda, Dun & Bradstreet CreditSME – founded by Adam Welsh, a former M&A and debt at Origin Capital Group and Goldman Sachs – is offering a sort of broker role, giving them a credit rating and then advising them on which lenders would be the best for them – be it traditional bank or online unsecured lenders. CreditSME, launching on Wednesday, is the latest in an explosion of ex investment banker-led fintechs targeting the small businesses traditionally treated with disdain by the banks. But it’s not lending them money, rather it wants to give SMEs (and their lenders) easy access to a credit rating, just like a big business. There are various operators that do this already – including Veda Group and Dun & Bradstreet. But CreditSME’s primary customer is the small business rather than the bank, so it will get access to all their financials, which it claims will make for a more accurate assessment more akin to the big ratings agencies. Typically, an SME will go to their bank to ask for a loan, with a small number considering the numerous online alternatives that have cropped up in recent years. But CreditSME – founded by Adam Welsh, a former M&A and debt banker at Origin Capital Group and Goldman Sachs – is offering a sort of broker role. It gives them a credit rating and then advises them on which lenders would be the best for them – be it traditional bank or online unsecured lenders. It says it has 15 lenders – banks, and non-bank lenders – signed up to accept its credit ratings, saving them the trouble of doing the credit checks themselves. CreditSME will make its money by charging a flat fee to the borrower starting at around $160 for a rating, ranging up to around $500 for advice on how to maintain their credit rating, and which types of loans will be best for them.
Origin Capital Group Investments
15 Investments
Origin Capital Group has made 15 investments. Their latest investment was in Locus Pharmaceuticals as part of their Unattributed VC - II on July 7, 2010.

Origin Capital Group Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
7/13/2010 | Unattributed VC - II | Locus Pharmaceuticals | $1.68M | No | Allianz, Amerindo Investment Advisors, ATEL Ventures, BioVenture Fund, Columbia Management, Cooper Hill Partners, Delphi Ventures, First-Tier Biotechnology Partners, HBM Healthcare Investments, HBM Partners, Invesco Private Capital, Jefferies Capital Partners, Johnson & Johnson Innovation, L Capital Partners, Life Science Venture Fund, Novartis Venture Funds, Origin Capital Group, Prism VentureWorks, ReqMed, SR One, Tredegar, and W Capital Partners | |
11/20/2001 | Series C | Locus Pharmaceuticals | $40M | No | ||
5/22/2001 | Series A | Dyadic International | $13.6M | Yes | ||
4/9/2001 | Series C | |||||
12/7/2000 | Unattributed VC - III |
Date | 7/13/2010 | 11/20/2001 | 5/22/2001 | 4/9/2001 | 12/7/2000 |
---|---|---|---|---|---|
Round | Unattributed VC - II | Series C | Series A | Series C | Unattributed VC - III |
Company | Locus Pharmaceuticals | Locus Pharmaceuticals | Dyadic International | ||
Amount | $1.68M | $40M | $13.6M | ||
New? | No | No | Yes | ||
Co-Investors | Allianz, Amerindo Investment Advisors, ATEL Ventures, BioVenture Fund, Columbia Management, Cooper Hill Partners, Delphi Ventures, First-Tier Biotechnology Partners, HBM Healthcare Investments, HBM Partners, Invesco Private Capital, Jefferies Capital Partners, Johnson & Johnson Innovation, L Capital Partners, Life Science Venture Fund, Novartis Venture Funds, Origin Capital Group, Prism VentureWorks, ReqMed, SR One, Tredegar, and W Capital Partners | ||||
Sources |
Origin Capital Group Portfolio Exits
3 Portfolio Exits
Origin Capital Group has 3 portfolio exits. Their latest portfolio exit was R2 Technology on July 13, 2006.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
7/13/2006 | Acquired | 1 | |||
Date | 7/13/2006 | ||
---|---|---|---|
Exit | Acquired | ||
Companies | |||
Valuation | |||
Acquirer | |||
Sources | 1 |